ATE26400T1 - Zur erhoehung des tyrosin-spiegels im gehirn zu verwendende zusammensetzungen. - Google Patents

Zur erhoehung des tyrosin-spiegels im gehirn zu verwendende zusammensetzungen.

Info

Publication number
ATE26400T1
ATE26400T1 AT83300131T AT83300131T ATE26400T1 AT E26400 T1 ATE26400 T1 AT E26400T1 AT 83300131 T AT83300131 T AT 83300131T AT 83300131 T AT83300131 T AT 83300131T AT E26400 T1 ATE26400 T1 AT E26400T1
Authority
AT
Austria
Prior art keywords
compositions used
increase brain
tyrosine levels
brain tyrosine
levels
Prior art date
Application number
AT83300131T
Other languages
English (en)
Inventor
Richard J Wurtman
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE26400T1 publication Critical patent/ATE26400T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT83300131T 1982-01-11 1983-01-11 Zur erhoehung des tyrosin-spiegels im gehirn zu verwendende zusammensetzungen. ATE26400T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/338,682 US4542123A (en) 1982-01-11 1982-01-11 Composition and method for increasing brain tyrosine levels
EP83300131A EP0083993B1 (de) 1982-01-11 1983-01-11 Zur Erhöhung des Tyrosin-Spiegels im Gehirn zu verwendende Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE26400T1 true ATE26400T1 (de) 1987-04-15

Family

ID=23325704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83300131T ATE26400T1 (de) 1982-01-11 1983-01-11 Zur erhoehung des tyrosin-spiegels im gehirn zu verwendende zusammensetzungen.

Country Status (6)

Country Link
US (1) US4542123A (de)
EP (1) EP0083993B1 (de)
JP (1) JPS58164505A (de)
AT (1) ATE26400T1 (de)
CA (1) CA1202902A (de)
DE (1) DE3370762D1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006559A (en) * 1988-08-31 1991-04-09 Clintec Nutrition Co. Method of use of branched-chain amino acids infusions to influence appetite
US5118670A (en) * 1988-12-14 1992-06-02 Massachusetts Institute Of Technology Process and composition for increasing brain dopamine release
US5698525A (en) * 1989-04-03 1997-12-16 Interneuron Pharmaceuticals, Inc. Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)
US5432162A (en) * 1989-04-03 1995-07-11 Interneuron Pharmaceuticals, Inc. Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)
CA2131801A1 (en) * 1992-03-11 1993-09-16 Richard J. Wurtman Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)
US6129685A (en) * 1994-02-09 2000-10-10 The University Of Iowa Research Foundation Stereotactic hypothalamic obesity probe
US7077822B1 (en) 1994-02-09 2006-07-18 The University Of Iowa Research Foundation Stereotactic hypothalamic obesity probe
US5480865A (en) * 1994-02-25 1996-01-02 Parkinson's Charitable Trust Nutritional composition
US6294579B1 (en) 1999-10-11 2001-09-25 Joseph W. Carnazzo Method for improving delivery of tyrosine supplementation
US9040082B2 (en) 2011-06-24 2015-05-26 K-Pax Pharmaceuticals, Inc. Compositions and methods for treatment of chronic fatigue

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB475291A (en) * 1936-07-30 1937-11-17 Shigeru Mizuno Process of preparing nutritive amino-acid preparations
FR2034543A1 (en) * 1969-02-13 1970-12-11 Etd Experimentales Centre L-tyrosine contg compsn in glucose for - treating fatigue syndrome
FR2181462A1 (en) * 1972-04-25 1973-12-07 Johnson & Johnson Low residue dietetic mixts - contg amino acids and caloric substances
JPS5537528B2 (de) * 1972-12-11 1980-09-29
CH594367A5 (de) * 1974-05-17 1978-01-13 Brenner Beat Max
PH14773A (en) * 1976-01-01 1981-12-09 Kureha Chemical Ind Co Ltd Protein-bound polysaccharides
US4182756A (en) * 1977-11-21 1980-01-08 Abbott Laboratories High calorie solutions of low molecular weight glucose polymer mixtures useful for intravenous administration
ZA786856B (en) * 1977-12-23 1979-11-28 Beecham Group Ltd Oral formulations for human use
US4296119A (en) * 1978-04-24 1981-10-20 Massachusetts Institute Of Technology Process and composition for reducing blood pressure in animals
EP0005058B1 (de) * 1978-04-24 1984-10-17 Massachusetts Institute Of Technology Zusammensetzung zur Regulierung des Dopamin- oder Norepinephrin-Spiegels in Neuronen-Synapsen
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates
US4221906A (en) * 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides

Also Published As

Publication number Publication date
DE3370762D1 (en) 1987-05-14
EP0083993A1 (de) 1983-07-20
JPS58164505A (ja) 1983-09-29
EP0083993B1 (de) 1987-04-08
US4542123A (en) 1985-09-17
CA1202902A (en) 1986-04-08

Similar Documents

Publication Publication Date Title
ZA836222B (en) Compositions and their use in the production of dental restorations
ATE77960T1 (de) Verwendung von interleukin-1 zur induzierung der bildung von multipotenten haemopoietischen zellpopulationen.
DE3571043D1 (en) Gellan gum/gelatin blends
IL66256A (en) Water containing compositions comprising alkali metal salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants
IT8423949A0 (it) Composizione e procedimento per inibire le incrostazioni.
IT1181642B (it) Composti di fenetanolammina come stimolanti in medicina e procedimento per prepararli
ES8605956A1 (es) Procedimiento para preparar una composicion antiacido
ZA853529B (en) Alkaline refined gum and use therefor in improved well-treating compositions
ATE26400T1 (de) Zur erhoehung des tyrosin-spiegels im gehirn zu verwendende zusammensetzungen.
GR851572B (de)
ES460743A1 (es) Procedimiento para la obtencion de preparados medicinales con ph acido.
ES458123A1 (es) Un procedimiento para la preparacion de nuevos derivados de adenina.
GB1509977A (en) Remineralising composition
EP0178443A3 (en) Soaps and shampoos containing bioemulsifiers
IT1178324B (it) Procedimento e composizione per prevenire la placca dentaria e la gengivite
JPS56152896A (en) Benzotriazole composition dispersible to blended lubricant,manufacture thereof and lubricant composition
MY101855A (en) Compositions containing fixed combinations.
DE3480258D1 (en) Injectable therapeutic compositions containing stable s-adenosyl-l-methionine salts
IL55214A (en) Antibacterial compositions containing trimethoprim and other ingredients
JPS52129355A (en) Amplifier
IT8324146A0 (it) Scorrevole in due parti per ancorare parti di protesi dentarie.
GB2112613B (en) Improvements in or relating to tine assemblies and components therefor
EP0252033A3 (en) Utilization of the "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) utilizable in therapy for topical usage
IL80884A0 (en) Pharmaceutical compositions containing azapropazone
JO1445B1 (en) Liquid formulations to increase agricultural crops production

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee